Document is current
Any future updates will be listed below
-
Authors
,
Jung, Boris
,
Martinez, Mikaël
Claessens, Yann-Erick
Darmon, Michaël
Klouche, Kada
Lautrette, Alexandre
Levraut, Jacques
Maury, Eric
Oberlin, Mathieu
Terzi, Nicolas
Viglino, Damien
Yordanov, Youri
Claret, Pierre-Géraud
Bigé, Naïke http://orcid.org/0000-0002-2945-6293
- License Information
-
More Information
Article History
Received: 26 June 2019
Accepted: 30 July 2019
First Online: 15 August 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: The authors declare the following competing interests: B. Jung: Sedana Medical, Medtronic; M. Martinez: Astra Zeneca, Actélion; YE Claessens: Roche diagnostics, BioMérieux, Sanofi, Pfizer; M. Darmon: Sanofi, Gilead-Kite, Astute Medical, MSD, Astellas; A. Lautrette: Baxter, Frésénius; J. Levraut: LFB, Nova-Biomedical; E. Maury: General Electric Healthcare, Doran International, Vygon, AstraZeneca; N. Terzi: Boehringer Ingelheim, Pfizer; D. Viglino: Astra Zeneca, Mundipharma; Y. Yordanov: Mundipharma, Sanofi; PG Claret: Aspen, AstraZeneca, Daiichi Sankyo, Roche Diagnostics, Sanofi, Thermo Fisher Scientific. The remaining authors declare that they have no competing interests.
